Not sure there's any confusion. Also, nobody knows if they've launched a phase 3, they don't have to say anything about that until 2016. So, it's not that it appears that they haven't. We just don't know for sure. With regard to that article, yeah, it was written in 2011, but it's the outline of their program. Regardless that it's been 4 or so years, that doesn't make the info any less relevant. Every set of clinical studies take years to come to fruition.
What's positive about this at all is that we know the drug works on hair, and that concentration and delivery were the main issues. If you read that patent I posted, it seems they have cleared that up. I mentioned that article and the patent because I have been piecing together information.
If you read articles about the merger, it was done in part because of the pipeline products. Specifically, in ophthamology and aesthetics. Bimatoprost for hair falls under aesthetics, and if you look at their pipeline, there isn't a big moneymaker as something that works better than rogaine ANYWHERE on the scalp. Yea, we have to wait, but there is little reason to believe that this won't be the next effective treatment for hair loss.
By the way, the reason they haven't said anything about phase 2b IS because of the merger. It's about stock price, and if you read that article from 2011, it says that the stock jumped $10 a share last time they released any info about the drug. This was also during the thick of the recession. So, news does have an effect, and it's not time to release any yet.
What's positive about this at all is that we know the drug works on hair, and that concentration and delivery were the main issues. If you read that patent I posted, it seems they have cleared that up. I mentioned that article and the patent because I have been piecing together information.
If you read articles about the merger, it was done in part because of the pipeline products. Specifically, in ophthamology and aesthetics. Bimatoprost for hair falls under aesthetics, and if you look at their pipeline, there isn't a big moneymaker as something that works better than rogaine ANYWHERE on the scalp. Yea, we have to wait, but there is little reason to believe that this won't be the next effective treatment for hair loss.
By the way, the reason they haven't said anything about phase 2b IS because of the merger. It's about stock price, and if you read that article from 2011, it says that the stock jumped $10 a share last time they released any info about the drug. This was also during the thick of the recession. So, news does have an effect, and it's not time to release any yet.
Comment